Edesa Biotech
EDSA
10 hedge funds and large institutions have $81K invested in Edesa Biotech in 2020 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 0 closing their positions.
710% more capital invested
Capital invested by funds: $10K → $81K (+$71K)
25% more funds holding
Funds holding: 8 → 10 (+2)
0.02% more ownership
Funds ownership: 0.01% → 0.03% (+0.02%)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$32.2K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$6.96K |
| 3 |
CFD
Creative Financial Designs
Kokomo,
Indiana
|
+$68 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$991 |
| 2 |
Osaic Holdings
Scottsdale,
Arizona
|
-$23 |
EDSA Hedge Fund Activity: Q2 2020 in Review
10 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Edesa Biotech (EDSA) for Q2 2020, worth a combined $81K — up 710% from $10K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new EDSA positions and 0 closed out — a net gain of 2 holders — while 1 added to existing stakes and 2 trimmed.
The largest buyer was Credit Suisse, opening a new position worth an estimated $32.2K. The largest seller was Bank of America, cutting an estimated $991.
- 10 institutional investors held Edesa Biotech (EDSA) as of Q2 2020, up from 8 in Q1 2020.
- Funds reported $81K of Edesa Biotech stock for Q2 2020, up 710% quarter-over-quarter.
- 2 funds opened new Edesa Biotech positions in Q2 2020 and 0 closed out, a net change of +2 holders.
- The largest Edesa Biotech buyer in Q2 2020 was Credit Suisse, an estimated $32.2K added.
- The largest Edesa Biotech seller in Q2 2020 was Bank of America, an estimated $991 sold.
Based on aggregated 13F filings for Q2 2020.